Outcomes from COVID-19 across the range of frailty: excess mortality in fitter older people
| Autor: | Benjamin C Mcloughlin, Daniel Davis, Imran Mannan, Paul Knopp, Thomas E Webb, Arshad Rather, Amy Miles |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty South asia Socioeconomic position Coronavirus disease 2019 (COVID-19) Epidemiology Frail Elderly Pneumonia Viral Ethnic group 030204 cardiovascular system & hematology Betacoronavirus 03 medical and health sciences 0302 clinical medicine Older patients Humans Medicine 030212 general & internal medicine Mortality Pandemics Aged Aged 80 and over Excess mortality Frailty SARS-CoV-2 business.industry Mortality rate Brief Report COVID-19 3. Good health Hospitalization Cohort Female Coronavirus Infections business Older people 030217 neurology & neurosurgery Demography |
| Zdroj: | European Geriatric Medicine |
| DOI: | 10.1101/2020.05.22.20110486 |
| Popis: | Key summary points Aim To describe associations between frailty, ethnicity, socioeconomic position and mortality in a cohort of older patients presenting to hospital with COVID-19. Findings Frailty did not appear to be associated with mortality rates after COVID-19, though an interaction was evident indicating much larger excess mortality in fitter, compared with frailer patients. Message Frailty may not be a good measure of prognosis in COVID-19 and different mechanisms may underlie pathways to death depending on pre-morbid frailty. Purpose Our aim was to quantify the mortality from COVID-19 and identify any interactions with frailty and other demographic factors. Methods Hospitalised patients aged ≥ 70 were included, comparing COVID-19 cases with non-COVID-19 controls admitted over the same period. Frailty was prospectively measured and mortality ascertained through linkage with national and local statutory reports. Results In 217 COVID-19 cases and 160 controls, older age and South Asian ethnicity, though not socioeconomic position, were associated with higher mortality. For frailty, differences in effect size were evident between cases (HR 1.02, 95% CI 0.93–1.12) and controls (HR 1.99, 95% CI 1.46–2.72), with an interaction term (HR 0.51, 95% CI 0.37–0.71) in multivariable models. Conclusions Our findings suggest that (1) frailty is not a good discriminator of prognosis in COVID-19 and (2) pathways to mortality may differ in fitter compared with frailer older patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|